Inventor · disambiguated record
Simon Teanby Hodgson
Also filed as: HODGSON SIMON T · HODGSON SIMON TEANBY
28 granted patents·18 pending applications·170 citations·filing 1988–2024
96Inventor score
Files withKALVISTA PHARMACEUTICALS LTD17GLAXO GROUP LTD13GLAXO WELLCOME INC5BURROUGHS WELLCOME CO4ANCLIFF RACHAEL ANN2
Top patents by PatentIndex Score
46 records- 0191US10364238B2N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Jul 30, 2019·8 cites·16 claims
- 0289US10781181B2N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Sep 22, 2020·6 cites·36 claims
- 0389US10611758B2N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted Apr 7, 2020·4 cites·1 claims
- 0488US9533987B2Heterocyclic derivatesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jan 3, 2017·19 cites·27 claims
- 0588US5776951AAnti-atherosclerotic diaryl compoundsGLAXO WELLCOME INC·Filed 1994·Granted Jul 7, 1998·33 cites·11 claims
- 0687US2025074903A1N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein InhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0783US7615550B2Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonistsGLAXO GROUP LTD·Filed 2003·Granted Nov 10, 2009·17 cites·19 claims
- 0877US2022289729A1N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein InhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0976US11001578B2N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted May 11, 2021·0 cites·30 claims
- 1076US7560548B2Morpholin-acetamide derivatives for the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2005·Granted Jul 14, 2009·2 cites·1 claims
- 1176US7101882B2Morpholin-acetamide derivatives for the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2001·Granted Sep 5, 2006·8 cites·25 claims
- 1275US11084809B2N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Granted Aug 10, 2021·0 cites·15 claims
- 1374US5607929AAntiviral dibenzothiazepinone derivativesGLAXO WELLCOME INC·Filed 1992·Granted Mar 4, 1997·51 cites·6 claims
- 1472US11198691B2N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Granted Dec 14, 2021·0 cites·24 claims
- 1571US7884114B2CompoundsGLAXO GROUP LTD·Filed 2008·Granted Feb 8, 2011·1 cites·18 claims
- 1669US7622464B2Morpholinyl-urea derivatives for use in the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2003·Granted Nov 24, 2009·6 cites·12 claims
- 1769US2023250080A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1867US7989629B23-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disordersGLAXO GROUP LTD·Filed 2006·Granted Aug 2, 2011·1 cites·16 claims
- 1964US11613527B2Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Mar 28, 2023·0 cites·46 claims
- 2063US7157457B2Compounds useful in the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2001·Granted Jan 2, 2007·2 cites·6 claims
- 2163US2009163495A1Morpholin-acetamide derivatives for the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 2263US2022002275A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2359US2010075953A1Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonistsGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 2456US11180484B2Pyrazole derivatives as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2017·Granted Nov 23, 2021·0 cites·4 claims
- 2556US6043284AAnti-atherosclerotic diaryl compoundsGLAXO WELLCOME INC·Filed 1998·Granted Mar 28, 2000·6 cites·21 claims
- 2654US2024059691A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2752US8507543B2CompoundsHODGSON SIMON TEANBY·Filed 2012·Granted Aug 13, 2013·0 cites·4 claims
- 2851US2009105225A12-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 AntagonistsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2950US5091531AN-imidaxo[1,2-b]pyridazinyl carbamatesBURROUGHS WELLCOME CO·Filed 1988·Granted Feb 25, 1992·3 cites·3 claims
- 3050US2008039444A1CompoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 3149US2010222349A1Quinoline derivatives used to treat inflammatory and allergic diseasesGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 3248US8357716B2Pyrazole derivatives used as CCR4 receptor antagonistsGLAXO GROUP LTD·Filed 2010·Granted Jan 22, 2013·0 cites·16 claims
- 3348US2022289727A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 3443US2006019964A1CompoundsANCLIFF RANCHAEL A·Filed 2005·Application pending·0 cites
- 3543US2022298138A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 3643US2022298141A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 3742US5380759AMethyl N-[6-(3,4,5-trimethoxybenzloxy)imidazo[1,2-b]pyridazin-2-zyl]carbamate used to treat leukemiaBURROUGHS WELLCOME CO·Filed 1993·Granted Jan 10, 1995·2 cites·2 claims
- 3840US2008207638A1CompoundsANCLIFF RACHAEL ANN·Filed 2006·Application pending·0 cites
- 3939US8304446B2CompoundsHODGSON SIMON TEANBY·Filed 2010·Granted Nov 6, 2012·0 cites·5 claims
- 4039US2008275027A1Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse AgonistsANCLIFF RACHAEL ANN·Filed 2006·Application pending·0 cites
- 4138US2006058299A1N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditionsANCLIFF RACHAEL A·Filed 2003·Application pending·0 cites
- 4236US2021238162A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
- 4335US5589474ADibenzothiazepinthione as antiviral agentsGLAXO WELLCOME INC·Filed 1992·Granted Dec 31, 1996·1 cites·10 claims
- 4433US5538970ATreatment of cancer with imidazo-1,2-pyridazin compoundsGLAXO WELLCOME INC·Filed 1995·Granted Jul 23, 1996·0 cites·2 claims
- 4532US5447956ATreatment of leukemia with a imidazo carbamateBURROUGHS WELLCOME CO·Filed 1994·Granted Sep 5, 1995·0 cites·1 claims
- 4632US5371219AImidazopyridazine derivativesBURROUGHS WELLCOME CO·Filed 1993·Granted Dec 6, 1994·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →